Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2012 (2012), Article ID 418345, 10 pages
http://dx.doi.org/10.1155/2012/418345
Research Article

Incremental Healthcare Expenditures Associated with Thyroid Disorders among Individuals with Diabetes

Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, P.O. Box 9510, Morgantown, WV-26505, USA

Received 12 August 2012; Revised 27 October 2012; Accepted 6 November 2012

Academic Editor: C. Marcocci

Copyright © 2012 Amit D. Raval and Usha Sambamoorthi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Prevalence and impact of thyroid disease,” 2012, http://www.thyroid.org/thyroid-events-education-media/about-hypothyroidism/.
  2. J. J. Díez, P. Sánchez, and P. Iglesias, “Prevalence of thyroid dysfunction in patients with type 2 diabetes,” Experimental and Clinical Endocrinology and Diabetes, vol. 119, no. 4, pp. 201–207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Perros, R. J. McCrimmon, G. Shaw, and B. M. Frier, “Frequency of thyroid dysfunction in diabetic patients: value of annual screening,” Diabetic Medicine, vol. 12, no. 7, pp. 622–627, 1995. View at Google Scholar · View at Scopus
  4. A. Papazafiropoulou, A. Sotiropoulos, A. Kokolaki, M. Kardara, P. Stamataki, and S. Pappas, “Prevalence of thyroid dysfunction among greek type 2 diabetic patients attending an outpatient clinic,” Journal of Clinical Medicine and Research, vol. 2, no. 2, pp. 75–78, 2010. View at Google Scholar
  5. D. H. Akbar, M. M. Ahmed, and J. Al-Mughales, “Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics,” Acta Diabetologica, vol. 43, no. 1, pp. 14–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Wu, “Thyroid disease and diabetes,” Clinical Diabetes, vol. 18, pp. 38–39, 2000. View at Google Scholar
  7. G. Dimitriadis, B. Baker, H. Marsh et al., “Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans,” The American Journal of Physiology, vol. 248, no. 5, part 1, pp. E593–E601, 1985. View at Google Scholar · View at Scopus
  8. G. Dimitriadis, P. Mitrou, V. Lambadiari et al., “Insulin action in adipose tissue and muscle in hypothyroidism,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 12, pp. 4930–4937, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. N. M. O'Meara, J. D. Blackman, J. Sturis, and K. S. Polonsky, “Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism,” Journal of Clinical Endocrinology and Metabolism, vol. 76, no. 1, pp. 79–84, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Okajima and M. Ui, “Metabolism of glucose in hyper- and hypo-thyroid rats in vivo. Relation of catecholamine actions to thyroid activity in controlling glucose turnover,” Biochemical Journal, vol. 182, no. 2, pp. 585–592, 1979. View at Google Scholar · View at Scopus
  11. K. S. Leong, M. Wallymahmed, J. Wilding, and I. MacFarlane, “Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes,” Postgraduate Medical Journal, vol. 75, no. 886, pp. 467–470, 1999. View at Google Scholar · View at Scopus
  12. P. Cettour-Rose, C. Theander-Carrillo, C. Asensio et al., “Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion,” Diabetologia, vol. 48, no. 4, pp. 624–633, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Maratou, D. J. Hadjidakis, A. Kollias et al., “Studies of insulin resistance in patients with clinical and subclinical hypothyroidism,” European Journal of Endocrinology, vol. 160, no. 5, pp. 785–790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. R. J. Levin and D. H. Smyth, “The effect of the thyroid gland on intestinal absorption of hexoses,” The Journal of physiology, vol. 169, pp. 755–769, 1963. View at Google Scholar · View at Scopus
  15. A. J. Matty and B. Seshadri, “Effect of thyroxine on the isolated rat intestine,” Gut, vol. 6, pp. 200–202, 1965. View at Google Scholar · View at Scopus
  16. H. F. Kemp, H. S. Hundal, and P. M. Taylor, “Glucose transport correlates with GLUT2 abundance in rat liver during altered thyroid status,” Molecular and Cellular Endocrinology, vol. 128, no. 1-2, pp. 97–102, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Mokuno, K. Uchimura, R. Hayashi et al., “Glucose transporter 2 concentrations in hyper- and hypothyroid rat livers,” Journal of Endocrinology, vol. 160, no. 2, pp. 285–289, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Vaughan, “An in vitro effect of triiodothyronine on rat adipose tissue,” Journal of Clinical Investigation, vol. 46, no. 9, pp. 1482–1491, 1967. View at Google Scholar · View at Scopus
  19. H. S. Chen, T. E. J. Wu, T. S. Jap et al., “Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients,” Diabetic Medicine, vol. 24, no. 12, pp. 1336–1344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Singer, “Of mice and men and elephants: metabolic rate sets glomerular filtration rate,” American Journal of Kidney Diseases, vol. 37, no. 1, pp. 164–178, 2001. View at Google Scholar · View at Scopus
  21. J. G. Den Hollander, R. W. Wulkan, M. J. Mantel, and A. Berghout, “Correlation between severity of thyroid dysfunction and renal function,” Clinical Endocrinology, vol. 62, no. 4, pp. 423–427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. G. R. Yang, J. K. Yang, L. Zhang, Y. H. An, and J. K. Lu, “Association between subclinical hypothyroidism and proliferative diabetic retinopathy in type 2 diabetic patients: a case-control study,” Tohoku Journal of Experimental Medicine, vol. 222, no. 4, pp. 303–310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. T.-H. Collet, J. Gussekloo, D. C. Bauer et al., “Subclinical hyperthyroidism and the risk of coronary heart disease and mortality,” Archives of Internal Medicine, vol. 172, no. 10, pp. 799–809, 2012. View at Publisher · View at Google Scholar
  24. R. Bunevičius and A. J. Prange, “Thyroid disease and mental disorders: cause and effect or only comorbidity?” Current Opinion in Psychiatry, vol. 23, no. 4, pp. 363–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. L. T. Dilas, T. Icin, J. N. Paro, and I. Bajkin, “Autoimmune thyroid disease and other non-endocrine autoimmune diseases,” Medicinski Pregled, vol. 64, pp. 3183–3147, 2011. View at Google Scholar
  26. T. C. Robazzi and F. F. Adan, “Autoimmune thyroid disease in patients with rheumatic diseases,” Revista Brasileira de Reumatologia, vol. 52, no. 3, pp. 423–430, 2012. View at Google Scholar
  27. M. D. Williams, R. Harris, C. M. Dayan, J. Evans, J. Gallacher, and Y. Ben-Shlomo, “Thyroid function and the natural history of depression: findings from the Caerphilly Prospective Study (CaPS) and a meta-analysis,” Clinical Endocrinology, vol. 70, no. 3, pp. 484–492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Mitrou, S. A. Raptis, and G. Dimitriadis, “Thyroid disease in older people,” Maturitas, vol. 70, no. 1, pp. 5–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. T. P. Gilmer, P. J. O'Connor, W. A. Rush et al., “Predictors of health care costs in adults with diabetes,” Diabetes Care, vol. 28, no. 1, pp. 59–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. Trogdon and T. Hylands, “Nationally representative medical costs of diabetes by time since diagnosis,” Diabetes Care, vol. 31, no. 12, pp. 2307–2311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Z. Fu, Y. Qiu, L. Radican, and B. J. Wells, “Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions,” Diabetes Care, vol. 32, no. 12, pp. 2187–2192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. Agency for Healthcare Research and Quality, “The medical expenditure panel survey: household component full year files, MEPS HC-129 2009 full year consolidated data file,” 2012, http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h129/h129doc.pdf.
  33. Agency for Healthcare Research and Quality, “The medical expenditure panel survey: MEPS HC-123: 2009 full year population characteristics,” 2012, http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h123/h123doc.pdf.
  34. “Bureau of labor statistics: consumer price index,” 2012, http://www.bls.gov/cpi/#tables.
  35. Medical Expenditure Panel Survey, “use and expenditures related to thyroid disease among women age 18 and older, U.S. noninstitutionalized population,” Statistical Report no. 348, 2008, http://meps.ahrq.gov/mepsweb/data_files/publications/st348/stat348.pdf.
  36. J. L. Rosenzweig, K. Weinger, L. Poirier-Solomon, and M. Rushton, “Use of a disease severity index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus,” American Journal of Managed Care, vol. 8, no. 11, pp. 950–958, 2002. View at Google Scholar · View at Scopus
  37. E. N. Pearce, “In people with subclinical hypothyroidism, TSH level >10 mIU/l may predict increased risk of coronary heart disease and related mortality,” Evidence-Based Medicine, vol. 16, no. 1, pp. 31–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. American Diabetes Association, “Economic costs of diabetes in the U.S. in 2007,” Diabetes Care, vol. 31, no. 3, pp. 596–615.
  39. R. Halvorsen and R. Palmquist, “The interpretation of dummy variables in semilogarithmic equations,” American Economic Review, vol. 70, no. 3, pp. 474–475, 1980. View at Google Scholar
  40. K. Zanocco, M. Heller, D. Elaraj, and C. Sturgeon, “Is subtotal thyroidectomy a cost-effective treatment for Graves disease? A cost-effectiveness analysis of the medical and surgical treatment options,” Surgery, vol. 152, no. 2, pp. 164–172, 2012. View at Google Scholar
  41. “Hospital stays for patients with diabetes, 2008,” 2012, http://www.hcup-us.ahrq.gov/reports/statbriefs/sb93.pdf.
  42. V. C. Woo, M. Carter, M. Bialy, and J. Rehman, “Emergency room visits: comparison of individuals with type 1 and type 2 diabetes,” 2012, http://professional.diabetes.org/Abstracts_Display.aspx?TYP=1&CID=55894.
  43. L. E. Egede, “Patterns and correlates of emergency department use by individuals with diabetes,” Diabetes Care, vol. 27, no. 7, pp. 1748–1750, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. American Diabetes Association, “Standards of medical care in diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11–S63, 2012. View at Google Scholar
  45. R. Kadiyala, R. Peter, and O. E. Okosieme, “Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies,” International Journal of Clinical Practice, vol. 64, no. 8, pp. 1130–1139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. MacHlin, J. Cohen, A. Elixhauser, K. Beauregard, and C. Steiner, “Sensitivity of household reported medical conditions in the medical expenditure panel survey,” Medical Care, vol. 47, no. 6, pp. 618–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. S. H. Zuvekas and G. L. Olin, “Validating household reports of health care use in the medical expenditure panel survey,” Health Services Research, vol. 44, no. 5, pp. 1679–1700, 2009. View at Publisher · View at Google Scholar · View at Scopus